New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
08:16 EDTAWAYHomeAway shares should be bought on weakness, says Pacific Crest
After speaking with HomeAway's management, Pacific Crest thinks the company's near-term trends have not changed since the company reported its Q1 results. The firm thinks that the company's business in Europe is tracking well, while its competitive position is strong. It cut its price target on the shares to $38 from $50 but keeps an Outperform rating on the stock.
News For AWAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
12:49 EDTAWAYOn The Fly: Top stock stories at midday
Subscribe for More Information
09:20 EDTAWAYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: eHealth (EHTH), up 24.7%... Starbucks (SBUX), up 4.2%... Microsoft (MSFT), up 5.2%... Google (GOOG, GOOGL), up 3.2% and up 3.7%, respectively... Amazon (AMZN), up 12% after reporting quarterly results and announcing shopping app for Apple Watch... Gigamon (GIMO), up 16.5%... Juniper Networks (JNPR), up 6.6%. ALSO HIGHER: Molycorp (MCP), up 10.2% following a Bloomberg report that China's export tax decision may boost rare earth demand... Mattel (MAT), up 4.4% after being upgraded to Buy from Neutral at Goldman... Innocoll (INNL), up 13.1% after 3.3M share Secondary priced at $9.00... Cytosorbents (CTSO), up 9.7% after CEO comments on CytoSorb in letter to shareholders. DOWN AFTER EARNINGS: Biogen (BIIB), down 4.7%... Altera (ALTR), down 1.7%... Pandora (P), down 4%... ResMed (RMD), down 8.7%... Xerox (XRX), down 4.7%... HomeAway (AWAY), down 3.6% after reporting quarterly results and departure of officers. ALSO LOWER: Ubiquiti (UBNT), down 14.4% following CFO resignation and preliminary third quarter results... 3D Systems (DDD), down 10.4% after reporting preliminary first quarter results... StemCells (STEM), down 23.2% after filing to sell common stock... Aerie Pharmaceuticals (AERI), down 54.7% after Rhopressa Phase 3 trial did not meet primary endpoint.
09:14 EDTAWAYHomeAway downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded HomeAway to Outperform and lowered its price target to $35 from $40 following lowered 2015 revenue and EBITDA guidance, a slower pay-per-booking revenue ramp, and the retirement of co-founder Carl Shephard and resignation of COO Brent Bellm. The firm remains positive on HomeAway long-term and views the company as an attractive takeover target.
April 23, 2015
19:16 EDTAWAYOn The Fly: After Hours Movers
Subscribe for More Information
17:57 EDTAWAYHomeAway COO Bellm, CSO Shepherd to resign, Hale appointed COO
Subscribe for More Information
16:18 EDTAWAYHomeAway sees FY15 revenue $493M-$500M, consensus $513.24M
Subscribe for More Information
16:17 EDTAWAYHomeAway sees Q2 revenue $122M-$124M, consensus $129.62M
Subscribe for More Information
16:16 EDTAWAYHomeAway reports Q1 EPS 11c, consensus 13c
Subscribe for More Information
15:00 EDTAWAYNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use